{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T23:33:28Z","timestamp":1778974408140,"version":"3.51.4"},"reference-count":48,"publisher":"Japan Atherosclerosis Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,1,1]]},"DOI":"10.5551\/jat.56549","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T22:12:01Z","timestamp":1605651121000},"page":"69-81","source":"Crossref","is-referenced-by-count":2,"title":["Effect of Rivaroxaban and Clopidogrel Combination Therapy on In-Stent Responses After Everolimus-Eluting Stent Implantation in a Porcine Coronary Model"],"prefix":"10.5551","volume":"29","author":[{"given":"Daisuke","family":"Kitano","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"},{"name":"Division of Advanced Cardiovascular Imaging, Department of Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Migita","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Advanced Cardiovascular Imaging, Department of Medicine, Nihon University School of Medicine"},{"name":"Division of Cell Regeneration and Transplantation, Department of Functional Morphology, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Research Support Center, Research Institute of Medical Science, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Research Support Center, Research Institute of Medical Science, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Kurosawa","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsumasa","family":"Sudo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"},{"name":"Division of Advanced Cardiovascular Imaging, Department of Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Haruta","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Hiro","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"},{"name":"Division of Advanced Cardiovascular Imaging, Department of Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadateru","family":"Takayama","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Mitsumata","sequence":"additional","affiliation":[{"name":"Division of Pathology, Central Clinical Laboratory, Yamanashi Kosei Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Cell Regeneration and Transplantation, Department of Functional Morphology, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Okumura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"},{"name":"Cardiovascular Division, Osaka Police Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Singh I, Shafiq N, Pandhi P, Reddy S, Pattanaik S, Sharma Y, Malhotra S: Triple antiplatelet therapy vs. dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: an evidence-based approach to answering a clinical query. Br J Clin Pharmacol, 2009; 68: 4-13","DOI":"10.1111\/j.1365-2125.2009.03402.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Harper RW: Drug-eluting coronary stents--a note of caution. Med J Aust, 2007; 186: 253-255","DOI":"10.5694\/j.1326-5377.2007.tb00884.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Dewilde WJM, Oirbans T, Verheugt FWA, Kelder JC, De Smet BJGL, Herrman J-P, Adriaenssens T, Vrolix M, Heestermans AACM, Vis MM, Tijsen JGP, van\u2019t Hof AW, ten Berg JM, WOEST study investigators: Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet, 2013; 381: 1107-1115","DOI":"10.1016\/S0140-6736(12)62177-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Mega JL, Braunwald E, Wiviott SD, Bassand J-P, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KAA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FWA, Gibson CM, ATLAS ACS 2\u2013TIMI 51 Investigators: Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med, 2012; 366: 9-19","DOI":"10.1056\/NEJMoa1112277"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Gibson CM, Pinto DS, Chi G, Arbetter D, Yee M, Mehran R, Bode C, Halperin J, Verheugt FWA, Wildgoose P, Burton P, van Eickels M, Korjian S, Daaboul Y, Jain P, Lip GYH, Cohen M, Peterson ED, Fox KAA: Recurrent hospitalization among patients with atrial fibrillation undergoing intracoronary stenting treated with 2 treatment strategies of rivaroxaban or a dose-adjusted oral vitamin K antagonist treatment strategy. Circulation, 2017; 135: 323-333","DOI":"10.1161\/CIRCULATIONAHA.116.025783"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, ten Berg JM, Steg PG, Hohnloser SH, RE-DUAL PCI Steering Committee and Investigators: Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med, 2017; 377: 1513-1524","DOI":"10.1056\/NEJMoa1708454"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Birmingham M, Ianus J, Burton P, van Eickels M, Korjian S, Daaboul Y, Lip GYH, Cohen M, Husted S, Peterson ED, Fox KA: Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med, 2016; 375: 2423-2434","DOI":"10.1056\/NEJMoa1611594"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, Averkov O, Bahit MC, Berwanger O, Budaj A, Hijazi Z, Parkhomenko A, Sinnaeve P, Storey RF, Thiele H, Vinereanu D, Granger CB, Alexander JH, AUGUSTUS Investigators: Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med, 2019; 380: 1509-1524","DOI":"10.1056\/NEJMoa1817083"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Lopes RD, Hong H, Harskamp RE, Bhatt DL, Mehran R, Cannon CP, Granger CB, Verheugt FWA, Li J, ten Berg JM, Sarafoff N, Gibson CM, Alexander JH: Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: A network meta-analysis of randomized controlled trials. JAMA Cardiol, 2019; 4: 747-755","DOI":"10.1001\/jamacardio.2019.1880"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Becker EM, Perzborn E, Klipp A, L\u00fccker C, B\u00fctehorn U, Kast R, Badimon JJ, Laux V: Effects of rivaroxaban, acetylsalicylic acid and clopidogrel as monotherapy and in combination in a porcine model of stent thrombosis. J Thromb Haemost, 2012; 10: 2470-2480","DOI":"10.1111\/jth.12033"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kubo T, Akasaka T, Kozuma K, Kimura K, Kawamura M, Sumiyoshi T, Ino Y, Morino Y, Tanabe K, Kadota K, Kimura T, RESET Investigators: Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial). EuroIntervention, 2015; 11: 564-571","DOI":"10.4244\/EIJV11I5A109"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kim J-S, Afari ME, Ha J, Tellez A, Milewski K, Conditt G, Cheng Y, Hua Yi G, Kaluza GL, Granada JF: Neointimal patterns obtained by optical coherence tomography correlate with specific histological components and neointimal proliferation in a swine model of restenosis. Eur Heart J Cardiovasc Imaging, 2014; 15: 292-298","DOI":"10.1093\/ehjci\/jet162"},{"key":"13","unstructured":"13) Tanigawa J, Barlis P, Di Mario C: Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition. EuroIntervention, 2007; 3: 128-136"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Malik N, Gunn J, Holt C, Shepherd L, Francis S, Newman C, Crossman D, Cumberland D: Intravascular stents: a new technique for tissue processing for histology, immunohistochemistry, and transmission electron microscopy. Heart, 1998; 80: 509-516","DOI":"10.1136\/hrt.80.5.509"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Rippstein P, Black MK, Boivin M, Veinot JP, Ma X, Chen Y-X, Human P, Zilla P, O\u2019Brien ER: Comparison of processing and sectioning methodologies for arteries containing metallic stents. J Histochem Cytochem, 2006; 54: 673-681","DOI":"10.1369\/jhc.5A6824.2006"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Schwartz RS, Edelman ER, Carter A, Chronos N, Rogers C, Robinson KA, Waksman R, Weinberger J, Wilensky RL, Jensen DN, Zuckerman BD, Virmani R, Consensus Committee: Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation, 2002; 106: 1867-1873","DOI":"10.1161\/01.CIR.0000033485.20594.6F"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Schneider CA, Rasband WS, Eliceiri KW: NIH Image to ImageJ: 25 years of image analysis. Nat Methods, 2012; 9: 671-675","DOI":"10.1038\/nmeth.2089"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR: Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model. J Am Coll Cardiol, 1992; 19: 267-274","DOI":"10.1016\/0735-1097(92)90476-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Hofma SH, Whelan DMC, van Beusekom HMM, Verdouw PD, van der Giessen WJ: Increasing arterial wall injury after long-term implantation of two types of stent in a porcine coronary model. Eur Heart J, 1998; 19: 601-609","DOI":"10.1053\/euhj.1997.0753"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Mori M, Sakata K, Nakanishi C, Nakahashi T, Kawashiri M, Yoshioka K, Takuwa Y, Okada H, Yokawa J, Shimojima M, Yoshimuta T, Yoshida S, Yamagishi M, Hayashi K: Early endothelialization associated with a biolimus A9 bioresorbable polymer stent in a porcine coronary model. Heart Vessels, 2017; 32: 1244-1252","DOI":"10.1007\/s00380-017-0992-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Orlandi A, Ehrlich HP, Ropraz P, Spagnoli L G, Gabbiani G: Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Arterioscler Thromb, 1994; 14: 982-989","DOI":"10.1161\/01.ATV.14.6.982"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Hao H, Gabbiani G, Bochaton-Piallat ML: Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol, 2003; 23: 1510-1520","DOI":"10.1161\/01.ATV.0000090130.85752.ED"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Escuer J, Mart\u00ednez MA, McGinty S, Pe\u00f1a E: Mathematical modelling of the restenosis process after stent implantation. J R Soc Interface, 2019; 16: 20190313","DOI":"10.1098\/rsif.2019.0313"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Rensen SSM, Doevendans PAFM, van Eys GJJM: Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J, 2007; 15: 100-108","DOI":"10.1007\/BF03085963"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Turley EA: Extracellular matrix remodeling: Multiple paradigms in vascular disease. Circ Res, 2001; 88: 2-4","DOI":"10.1161\/01.RES.88.1.2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Sugita S, Mizutani E, Hozaki M, Nakamura M, Matsumoto T: Photoelasticity-based evaluation of cellular contractile force for phenotypic discrimination of vascular smooth muscle cells. Sci Rep, 2019; 9: 3960","DOI":"10.1038\/s41598-019-40578-7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kawakami R, Hao H, Imanaka T, Shibuya M, Ueda Y, Tsujimoto M, Ishibashi-Ueda H, Hirota S: Initial pathological responses of second-generation everolimus-eluting stents implantation in Japanese coronary arteries: Comparison with first-generation sirolimus-eluting stents. J Cardiol, 2018; 71: 452-457","DOI":"10.1016\/j.jjcc.2017.11.009"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Costa MA, Simon DI: Molecular basis of restenosis and drug-eluting stents. Circulation, 2005; 111: 2257-2273","DOI":"10.1161\/01.CIR.0000163587.36485.A7"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Pearson JD: Endothelial cell function and thrombosis. Baillieres Clin Haematol, 1994; 7: 441-452","DOI":"10.1016\/S0950-3536(05)80092-7"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Toutouzas K, Colombo A, Stefanadis C: Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J, 2004; 25: 1679-1687","DOI":"10.1016\/j.ehj.2004.06.011"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Chandrasekar B, Tanguay JF: Platelets and restenosis. J Am Coll Cardiol, 2000; 35: 555-562","DOI":"10.1016\/S0735-1097(99)00596-3"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Ragosta M, Gimple LW, Gertz SD, Dunwiddie CT, Vlasuk GP, Haber HL, Powers ER, Roberts WC, Sarembock IJ: Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation, 1994; 89: 1262-1271","DOI":"10.1161\/01.CIR.89.3.1262"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Kaiser B, Paintz M, Scholz O, Kunitada S, Fareed J: A synthetic inhibitor of factor Xa, DX-9065a, reduces proliferation of vascular smooth muscle cells in vivo in rats. Thromb Res, 2000; 98: 175-185","DOI":"10.1016\/S0049-3848(99)00213-3"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Cheung WM, D\u2019Andrea MR, Andrade-Gordon P, Damiano BP: Altered vascular injury responses in mice deficient in protease-activated receptor-1. Arterioscler Thromb Vasc Biol, 1999; 19: 3014-3024","DOI":"10.1161\/01.ATV.19.12.3014"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Damiano BP, D\u2019Andrea MR, de Garavilla L, Cheung WM, Andrade-Gordon P: Increased expression of protease activated receptor-2 (PAR-2) in balloon-injured rat carotid artery. Thromb Haemost, 1999; 81: 808-814","DOI":"10.1055\/s-0037-1614574"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KKL, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Pocock SJ, Kuntz RE: A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med, 1998; 339: 1665-1671","DOI":"10.1056\/NEJM199812033392303"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Dorsam RT, Murugappan S, Ding Z, Kunapuli SP: Clopidogrel: interactions with the P2Y <sub>12<\/sub> receptor and clinical relevance. Hematology, 2003; 8: 359-365","DOI":"10.1080\/10245330310001621260"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Li M, Zhang Y, Ren H, Zhang Y, Zhu X: Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model. Atherosclerosis, 2007; 194: 348-356","DOI":"10.1016\/j.atherosclerosis.2006.11.006"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Virmani R, Kolodgie FD, Farb A, Lafont A: Drug eluting stents: are human and animal studies comparable? Heart, 2003; 89: 133-138","DOI":"10.1136\/heart.89.2.133"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Kilickesmez K, Dall\u2019Ara G, Rama-Merchan JC, Ghione M, Mattesini A, Vinues CM, Konstantinidis N, Pighi M, Estevez-Loureiro R, Zivelonghi C, Lindsay AC, Secco GG, Foin N, De Silva R, Di Mario C: Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents. Int J Cardiol Heart Vessels, 2014; 3: 68-74","DOI":"10.1016\/j.ijchv.2014.03.003"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Shi S-Y, Chen K-L, Gu J, Xu C, Chen Q-R, Chen Y-Q, Xu T, Ke H-Y, Sun J-H, Ye F: Correlation between pre-procedural plaque morphology and patterns of in-stent neointimal hyperplasia at 1-year follow-up in patients treated with new-generation drug-eluting stents: An optical coherence tomography based analysis. J Interv Cardiol, 2018; 31: 737-746","DOI":"10.1111\/joic.12555"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Kim J-S, Lee J-H, Shin D-H, Kim B-K, Ko Y-G, Choi D, Jang Y, Hong M-K: Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation. JACC Cardiovasc Imaging, 2014; 7: 788-795","DOI":"10.1016\/j.jcmg.2014.05.004"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Gibson CM, Chakrabarti AK, Mega J, Bode C, Bassand J-P, Verheugt FWA, Bhatt DL, Goto S, Cohen M, Mohanavelu S, Burton P, Stone G, Braunwald E, ATLAS-ACS 2 TIMI 51 Investigators: Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51. J Am Coll Cardiol, 2013; 62: 286-290","DOI":"10.1016\/j.jacc.2013.03.041"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, G\u00fcray \u00dc, Park D-W, Bode C, Welsh RC, Gibson CM: Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet, 2017; 389: 1799-1808","DOI":"10.1016\/S0140-6736(17)30751-1"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O\u2019Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, St\u00f6rk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim J-H, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S, COMPASS Investigators: Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med, 2017; 377: 1319-1330","DOI":"10.1056\/NEJMoa1709118"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Gurbel PA, Tantry US: GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes. Lancet, 2017; 389: 1773-1775","DOI":"10.1016\/S0140-6736(17)30760-2"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H, AFIRE Investigators: Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Engl J Med, 2019; 381: 1103-1113","DOI":"10.1056\/NEJMoa1904143"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Chaabane C, Otsuka F, Virmani R, Bochaton-Piallat ML: Biological responses in stented arteries. Cardiovasc Res, 2013; 99: 353-363","DOI":"10.1093\/cvr\/cvt115"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/1\/29_56549\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:37:06Z","timestamp":1715143026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/1\/29_56549\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.56549","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]},"article-number":"56549"}}